ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Otrivin® Heuschnupfen:NOVARTIS CONSUMER HEALTH SCHWEIZ AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
R01AC03 - AzelastineATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R01 - Nasal Preparations
 
R01A - Decongestants and Other Nasal Preparations for Topical Use

This group comprises preparations for local treatment in nasal congestion (e.g. sympathomimetics) or for prophylaxis and treatment of allergic rhinitis (e.g. corticosteroids, cromoglicate preparations). Most of the products are nasal drops, nasal sprays or nasal inhalants. Formulations approved for eye, ear and nose are classified in S03.
See also R01B - Nasal decongestants for systemic use, and
R06 - Antihistamines for systemic use.

The DDDs are based on treatment of both nostrils.

R01AC - Antiallergic Agents, Excl. Corticosteroids

Antihistamines, cromoglicate disodium and analogues are classified here. Combinations with corticosteroids are classified in R01AD.

The DDD of cromoglicic acid is based on the prophylaxis of rhinitis. The DDDs of the antihistamines are based on the maintenance treatment of rhinitis.

R01AC03 - Azelastine
StärkeAdm.RouteNote
 N 
2022 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home